Medical Devices North America

North America Biological Age Testing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $464.8 Mn Placeholder estimate
Estimate 2025 $520.1 Mn 50.9% of the global market
Projected 2034 $1.43 Bn 175.1% Adds $910.7 Mn over 9 forecast years
CAGR 2025–2034 11.9% Faster than 84% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • North America is 50.92% of the global market.
  • Among regions, the largest is North America (this report) at $520.1 Mn.
  • Fastest growing: Latin America at 14.3% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$910.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biological Age Testing Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $464.8 Mn — —
2025 (base) $520.1 Mn +$55.3 Mn —
2026 (forecast) $582.0 Mn +$61.9 Mn +11.9%
2027 (forecast) $651.3 Mn +$69.3 Mn +25.2%
2028 (forecast) $728.8 Mn +$77.5 Mn +40.1%
2029 (forecast) $815.5 Mn +$86.7 Mn +56.8%
2030 (forecast) $912.6 Mn +$97.0 Mn +75.4%
2031 (forecast) $1.02 Bn +$108.6 Mn +96.3%
2032 (forecast) $1.14 Bn +$121.5 Mn +119.7%
2033 (forecast) $1.28 Bn +$136.0 Mn +145.8%
2034 (forecast) $1.43 Bn +$152.2 Mn +175.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Biological Age Testing Market Analysis at a glance
Market size, 2025$520.1 Mn placeholder estimate
Forecast, 2034$1.43 Bn placeholder estimate
Growth (CAGR), 2025–203411.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, channel and end user (see all)
Key playersTruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all)
Active clinical trials48 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Biological Age Testing Market Analysis Executive Summary

Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.

Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).

Bar chart: North America Biological Age Testing market size, 2024–2034, placeholder estimates. $464.8 Mn in 2024, $520.1 Mn in 2025 and $1.43 Bn in 2034, 11.9% CAGR.
North America Biological Age Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Biological Age Testing Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.

Competitive Landscape for Biological Age Testing Market in North America

The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biological Age Testing Market in North America

Biological Age Testing in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 48 studies on Biological Age Testing that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biological Age Testing right now, from free public sources.

Clinical trials

48 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. Longevity Metrics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Nutraland USA, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Elysium Health 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 17 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biological Age Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biological Age Testing market in North America?
Placeholder estimate: about $520.1 Mn in 2025, rising to about $1.43 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biological Age Testing market in North America growing?
Placeholder estimate: about 11.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biological Age Testing market report cover?
The report splits the market by test (Epigenetic Clocks, Blood Biomarker Panels, Telomere Tests, Multi-Omic Tests), channel (Direct-to-Consumer, Clinics, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Biological Age Testing market?
Key players include TruDiagnostic, Tally Health, InsideTracker, GlycanAge and Elysium Health.
What is driving the Biological Age Testing market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
How many clinical trials on Biological Age Testing are running in North America?
48 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Biological Age Testing?
PubMed lists 803 papers on Biological Age Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on geriatric and genomics

See the topic